Closed · ONDCP-DEW-2015 · CFDA 95.007 · Discretionary

Drug Early Warning from Re-Testing Biological Samples

Federal grant opportunity posted by Office of National Drug Control Policy, cataloged on Grants.gov.

$100K-$100K
Award range
Closed
Status
September 22, 2015
Close date
1
Expected awards

The verdict

Drug Early Warning from Re-Testing Biological Samples is a closed discretionary listing from Office of National Drug Control Policy that offered $100,000 -- $100,000 across 1 expected award. Future funding cycles may be published under the same CFDA number. PlainGrants indexes 54 other opportunities from Office of National Drug Control Policy.

$100K-$100K
award range
Closed
application status
1
expected award
95.007
CFDA program

Archived opportunity record

Drug Early Warning from Re-Testing Biological… is closed (last close September 22, 2015). Check the agency catalog for replacement NOFOs. Office of National Drug Control Policy still indexes 54 other opportunities here.

According to Grants.gov (extract vintage 2026-08-10), this record reflects the officially published listing. See methodology.

Deadline tracker

Application window closed

Closed September 22, 2015

Posted Sep 16 Closes Sep 22

Est. Total Funding

$100,000

Expected Awards

1

Instrument

Cooperative Agreement

Description

The Office of National Drug Control Policy (ONDCP), Executive Office of the President, is seeking applications from public nonprofit institutions/organizations (includes institutions of higher education and hospitals) to perform research and analysis of data to inform drug policy. This project seeks to further refine a methodology for obtaining drug early warning indicators from expanded testing of urine samples that were previously collected and tested as part of an existing drug test protocol. This method was initially developed using local criminal justice populations – including persons in pre-trial or lock-up, parolees or probationers, and drug court participants. Similar methodology is promising for use in other venues, such as in trauma units and emergency departments, where biological samples are often collected from patients. Before the specimens are discarded, the project will re-test them for an expanded panel of drugs, including synthetic cannabinoids, to determine what old and new illicit drugs are detected or missed by conventional testing protocols, and how the drug patterns might vary by subpopulation and geography. By passing the expense of collecting the original specimens and re-using those that have already been tested with known results yields a relatively inexpensive and timely picture of emerging drugs in a given subpopulation and locality. ONDCP expects to continue to engage the laboratory testing services of the Armed Forces Medical Examiner System (AFMES) at no charge to further minimize project costs.

Campus applicant desk · Science and Technology / R&D

Grants.gov prints only higher-education applicant doors for Drug Early Warning from Re-Testing Biological… (Public / state-controlled institutions of higher education). This reads as a campus competition desk, not a civic or commercial open call. The extract does not mark applicant cost-sharing as required. Instrument: Cooperative Agreement. Funding-activity code maps to Science and Technology / R&D (ST). Only 1 other Office of National Drug Control Policy listing share this exact eligibility-code string (2% of 55).

Code 06
Public / state-controlled institutions of higher education

Codes are Grants.gov eligibility category values from the extract vintage 2026-08-10. Confirm the full eligibility statement on the official listing or the Grants.gov eligibility reference.

Official Listing on Grants.gov

View full details, application forms, and submission instructions.

View on Grants.gov

Agency Contact

darren neely IT specialist Phone 2023955530

What to do next

Drug Early Warning from Re-Testing Biological… is closed; use the parent program and agency catalog for the next funding cycle.

  • Browse open federal opportunities in the same category when this listing is closed. Open opportunities
  • Look up CFDA 95.007 across all indexed listings before you commit to this opportunity alone. Eligibility finder
  • Compare award ranges across federal categories before you pick a single CFDA. All categories

Opportunity deadlines and eligibility change on Grants.gov; PlainGrants mirrors the extract and is not the submission system.

Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.

Data sourced from the SAM.gov Assistance Listings and Grants.gov. See our methodology for details. Retrieved and formatted by PlainGrants